Lupin Tarapur unit: US FDA issues warning letter to Lupin’s Tarapur unit

The federal company had inspected Lupin’s Tarapur web site from March 22, 2022 to April 4, 2022.

Lupin in an announcement stated it doesn’t imagine that the warning letter will have an effect or disruption of provides or the prevailing revenues from operations of this facility.

“We’re dedicated to addressing the issues raised by the US FDA and can work with the US FDA to resolve these points on the earliest. We uphold high quality and compliance points with utmost significance and stay dedicated to be compliant with CGMP high quality requirements throughout all our amenities,” the corporate stated in a press launch.

As on 10:30 am, the inventory was buying and selling with losses of over 1% whereas the broader indices have been buying and selling up round 0.40%.